Login to Your Account

Trophos Receives €7M in Grants, Refocuses Development Efforts

By James Etheridge

Wednesday, December 24, 2008

No Abstract


BioWorld International Correspondent

PARIS - Trophos received €7 million (US$9.77 million) in funding for two projects involving the company's lead candidate, TRO19622, one of several cholesterol-oxime-based compounds it is developing for the treatment of neurodegenerative diseases.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription